소아 살스- 코브-2 감염병( SARS-Cov-2 infection /Severe Acute Respiratory syndrome–Coronavirus-2) . SARS-Cov-2 infection /Severe Acute Respiratory syndrome–Coronavirus-2

소아 살스– 코브– 2 감염병

SARS-Cov-2 infection / Severe Acute Respiratory Syndrome –Coronavirus -2

Coronavirus

PHIL ID #23311 | Download high-resolution image
Description:
This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by coronaviruses

검사 확진 소아 살스-코브-2 감염병 환자 171명의 주 증상은 기침, 인두발적, 열이었고 16% 소아들에게는 증상이 없었다.

중국 우환 소아 살스-코브-2 감염병 환자에서 얻은 임상 특이점을 살펴보면 다음과 같다.

1920년 1월부터 2월 26일까지 총 139명의 소아 살스– 코브– 2 감염병 환자들등 중
171명, 즉 12%- 살스– 코브– 2 감염병을 검사로 확인됐다.
그중 60%는 남아들.
소아 환자들의 중간 나이는 7세.
나이 범위는 1~15세.
27명의 검사 확진 소아 환자들(16%)은 폐렴도 없고 무증상이다.
가장 흔한 증상은 기침 49%과 열 42%
섭씨 39도이상 열이 나는 소아 환자는 9%
설사, 피곤, 콧물, 구토, 코 막힘 등의 증상은 흔하게 생기지 않는다.
111명의 소아 환자들에게는 폐렴이 있었고 그중 12명에게는 무증상이었다.
피검사에는 특이성이 없었으나 림프구 감소가 있었다 .
33%의 소아 환자들의 폐 CT 검사의 결과가 비정상이다.
3명의 소아 환자는 중환자실에서 치료를 받았고 기존 병이 있었다.
10개월 된 영아는 4주 입원 치료를 받았으나 사망했다.
소아 살스-코브-2 감염병에 걸린 소아들은 성인 환자들에 비해 덜 앓지만 폐렴이 있던 아아들은 회복 후 폐기능 에 문제가 있을 수 있다.

소스: NEJM, Journal Watch, May 2020.

Pediatric SARS-CoV-2 Infection
SARS-CoV-2 infection / Severe Acute Respiratory Syndrome – Coronavirus -2
Coronavirus

PHIL ID #23311 | Download high-resolution image
Description:
This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals the ultrastructural morphology exhibited by coronaviruses.

The primary symptoms observed in 171 laboratory-confirmed pediatric patients with SARS-CoV-2 infection were cough, pharyngeal erythema, and fever; notably, 16% of these children were asymptomatic.
The following clinical characteristics were observed in pediatric SARS-CoV-2 patients in Wuhan, China:
Between January and February 26, 2020, a total of 1,391 pediatric patients were evaluated; of these, 171—or 12%—were confirmed via laboratory testing to have SARS-CoV-2 infection.
Of the confirmed cases, 60% were male.
The median age of the pediatric patients was 7 years.
The age range spanned from 1 to 15 years.
Twenty-seven of the laboratory-confirmed pediatric patients (16%) were asymptomatic and showed no signs of pneumonia.
The most common symptoms were cough (49%) and fever (42%).
Only 9% of the pediatric patients presented with a fever exceeding 39°C.
Symptoms such as diarrhea, fatigue, rhinorrhea, vomiting, and nasal congestion were not commonly observed.
One hundred and eleven pediatric patients presented with pneumonia; among them, 12 were asymptomatic.
Laboratory blood tests did not reveal any specific markers, though lymphopenia was observed.
Chest CT scans revealed abnormal findings in 33% of the pediatric patients. Three pediatric patients received treatment in the intensive care unit and had underlying medical conditions.
A 10-month-old infant received inpatient treatment for four weeks but passed away.
While children infected with SARS-CoV-2 generally experience less severe illness compared to adult patients, those who developed pneumonia may face complications following their recovery.
Source: NEJM, Journal Watch, May 2020